Lung Diseases  >>  tetomilast (OPC-6535)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tetomilast (OPC-6535) / Otsuka
EMPHASIS, NCT00874497: Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Terminated
2
84
US
tetomilast, placebo
Otsuka Pharmaceutical Development & Commercialization, Inc.
Chronic Obstructive Pulmonary Disease
07/15
08/15

Download Options